Synephrine Derivatives for the Treatment of Cancer
This invention relates to a group of synephrine derivatives represented by the structural formula (I), a stereoisomer thereof, a solvate thereof, or a salt thereof, for use in the treatment of cancer, possessing unexpected desirable pharmaceutical properties, in particular for the use in cancer therapy or tumor treatment, especially for glucocorticoid-resistant treatment.
Attached files:Patents:WO 2,009,092,796
Inventor(s):
HAEGEMAN GUY [BE]; VANDEN BERGHE WIM [BE]; GERLO SARAH [BE]; HOYA ARIAS RUBEN [US]; DE BOSSCHER KAROLIEN [BE]
Type of Offer:
Sale
« More Medical Patents